Page last updated: 2024-09-04

barbigerone and Carcinoma, Non-Small Cell Lung

barbigerone has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, L; Li, X; Peng, A; Wang, X; Ye, H1

Other Studies

1 other study(ies) available for barbigerone and Carcinoma, Non-Small Cell Lung

ArticleYear
Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-small-cell lung cancer xenografts growth through VEGFR2 signaling pathways.
    Cancer chemotherapy and pharmacology, 2012, Volume: 70, Issue:3

    Topics: Angiogenesis Inhibitors; Animals; Carcinoma, Non-Small-Cell Lung; Cell Movement; Cell Proliferation; Collagen; Dose-Response Relationship, Drug; Drug Combinations; Human Umbilical Vein Endothelial Cells; Humans; Isoflavones; Laminin; Lung Neoplasms; Mice; Mice, Inbred C57BL; Mice, Nude; Neovascularization, Pathologic; Proteoglycans; Signal Transduction; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays; Zebrafish

2012